In the past decade, GAL3 has been found to be dysregulated or considered as a biomarker in various diseases including cardiac [45, 46], renal [45, 47], hepatic [48], cerebrovascular diseases [49], and many types of cancer [45, 50]. The gene discussed is LGALS3; the disease is cancer.